Drugs / Yuekang Huoxin Pills (concentrated pills)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05489016 | Aug 2022 → Jan 2024 | coronary artery disorder | China National Center for Cardiovascular Diseases | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yuekang Huoxin Pills (concentrated pills) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05489016 ↗ |
| Known as | Huoxin Pill (concentrated pill) | “Huoxin Pill (concentrated pill) is composed of Radix Ginseng, Radix Aconiti Lateralis Preparata, Ganoderma, Flos Carthami, artificial Moschus, cultured calculus bovis in vitro,...” NCT05489016 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Huoxin Pill(concentrated pills), a traditional Chinese medicine” NCT05489016 ↗ |